Ambulatory Blood Pressure Monitoring

End-organ damage related to hypertension is more intently related to ambulatory blood stress (ABP) than clinic or informal blood strain measurements. ABP measurements give higher prediction of clinical end result than clinic or informal blood pressure measurements. The technique of ABP monitoring (ABPM) is specialised; validated monitors and applicable quality management measures must be used. Interpretation of ABP profile should embrace imply daytime, night time-time (sleep) and 24-hour measurements, and consideration of diary info and time of drug therapy. Reports may include ABP "loads" (percentage area below the blood pressure curve above set limits) for daytime and night time-time periods. Percentage area below the blood pressure curve above set limits. Can solely be detected by ambulatory blood stress monitoring (ABPM) or self-monitoring. May not be benign; definitive consequence studies are wanted. Requires continued surveillance, involving self-monitoring and repeat ABPM at 1-2-year intervals. Does not reply to standard drug therapy. Department of Vascular Sciences, Dandenong Hospital, Dandenong, VIC. 1. Verdecchia P, Clement D, Faggard R, et al.



Blood Pressure Monitoring. Task power III. Target organ damage, morbidity and mortality. 2. Mancia G, Zanchetti A, Agabiti-Rosei E, et al. Ambulatory blood strain is superior to clinic blood stress in predicting therapy-induced regression of left ventricular hypertrophy. 3. Perloff D, Sokolow M, Cowan R, et al. Prognostic worth of ambulatory blood strain measurements: additional analysis. J Hypertens 1989; l 7: S3-S10. 4. Verdecchia P. Prognostic value of ambulatory blood stress. Current evidence and clinical implications. 5. Imai Y. Prognostic significance of ambulatory blood pressure. 6. Staessen J, Thijs L, Fagard R, et al. Predicting cardiovascular danger utilizing conventional vs ambulatory blood pressure in older patients with systolic hypertension. 7. Sokolow M, Werdegar D, Kain H, Hinman A. Relationship between level of blood strain measured casually and by portable recorders and severity of complications in essential hypertension. 8. O'Brien E, Petrie J, Littler WA, et al. The British Hypertension Society protocol for the analysis of blood strain measuring units.



J Hypertens 1993; 11: S43-S63. 9. Association for the Advancement of Medical Instrumentation. American National Standard. Electronic or automated sphygmomanometer. ANSI/AAMI SP 10-1992. Arlington, VA. 10. O'Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: suggestions of the British Hypertension Society. 11. O'Brien E, Waeber B, Parati G, et al. Blood stress measuring units: suggestions of the European Society of Hypertension. 12. O'Brien E. State of the market for gadgets for blood pressure measurement. 13. White WB. Blood stress load and target organ results in patients with important hypertension. J Hypertens 1991; 9: S39-S41. 14. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure. An unbiased predictor of prognosis in essential hypertension. 15. Steptoe A, Cropley M, Joekes K. Job strain, blood strain and response to uncontrollable stress. 16. Joint National Committee on Detection, Evaluation and Treatment of Hypertension. The sixth report of the Joint National Committee.



17. Guidelines Subcommittee. World Health Organization-International Society of Hypertension guidelines for the administration of hypertension. 18. Pickering T, BloodVitals SPO2 device for the American Society of Hypertension Ad-hoc Panel. Recommendations for the usage of house (self) and ambulatory blood strain monitoring. 19. Myers MG, Haynes RB, Rabkin SW. Canadian Hypertension Society pointers for ambulatory blood strain monitoring. 20. Staessen J, Beilin L, Parati G, et al. Task force IV: Clinical use of ambulatory blood pressure monitoring. 21. Staessen JA, Bytterbier G, Buntinx F, et al, for the Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. Antihypertensive remedy primarily based on typical or ambulatory blood stress measurement: a randomized controlled trial. 22. Beltman F, Hessen W, Kok R, et al. Predictive worth of ambulatory blood stress shortly after withdrawal of antihypertensive drugs in primary care patients. 23. McGrath BP. Is white coat hypertension innocent? 24. Staessen J, O'Brien E, Atkins N, et al. Ambulatory blood strain in normotensive compared with hypertensive topics. 25. Mancia G, Sega R, Bravi C, et al.



Ambulatory blood pressure normality: results from the PAMELA research. 26. Ohkubo T, Imai Y, Tsuju I, et al. Reference values for 24-hour ambulatory blood strain monitoring based on a prognostic criterion: the Ohasama Study. 27. Lurbe E, Redon J, Liao Y, et al. Ambulatory blood pressure monitoring in normotensive youngsters. 28. Brown MA, Robinson A, Bowyer L, et al. Ambulatory blood stress monitoring in pregnancy: what is normal ? 29. Silagy C, McNeil J, Farish S, McGrath B. Comparison of repeated measures of ambulatory and clinic blood strain readings in isolated systolic hypertension. 30. Pickering T, James G, Boddie C, et al. How frequent is white coat hypertension. 31. Palatini P, Dorigatti F, Roman E, et al. White-coat hypertension: a range bias? 32. Palatini P, Mormino P, Santonastaso M, et al. Target-organ injury in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST examine. 33. Kario K, Shimada K, Schwartz J, et al. Silent and clinically overt stroke in older Japanese topics with white-coat and sustained hypertension. 34. Herpin D, Pickering T, Sterglou G, et al. Consensus conference on self-blood pressure measurement. Clinical purposes and BloodVitals SPO2 device prognosis. 35. Self measurement of blood stress -- a paper for well being professionals. 36. Ewald B, Pekarsky B. Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug remedy in Australian common practice. 37. National Health and Medical Research Council. Guidelines for the development and implementation of clinical follow pointers. Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You can be notified by e-mail within five working days should your response be accepted.